Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy.
Ng
Heng Joo
HJ
St. Joseph's Hospital, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada. ng.heng.joo@sgh.com.sg
Crowther
Mark A
MA
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D018279:Carcinoma, Signet Ring Cell / Q000150:complications* / Q000473:pathology; D005260:Female; D005734:Gangrene / Q000188:drug therapy / Q000209:etiology*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D035002:Lower Extremity / Q000473:pathology; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009336:Necrosis; D009382:Neoplasms, Unknown Primary / Q000150:complications* / Q000473:pathology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy / Q000209:etiology*; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin